A new trading day began on Tuesday, with Prothena Corporation plc (NASDAQ: PRTA) stock price down -3.27% from the previous day of trading, before settling in for the closing price of $6.43. PRTA’s price has ranged from $4.32 to $25.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -3.15% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -71.81%. With a float of $42.32 million, this company’s outstanding shares have now reached $53.83 million.
In an organization with 163 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 57.64%, operating margin of -100.49%, and the pretax margin is -84.0%.
Prothena Corporation plc (PRTA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 21.38%, while institutional ownership is 70.17%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -71.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.63% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Here are Prothena Corporation plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -1.25 in the next quarter and is forecasted to reach -2.33 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.72 million. That was inferior than the volume of 1.07 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.14%.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 15.39%, which indicates a significant decrease from 41.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was lower than the 0.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.17, while its 200-day Moving Average is $12.32. However, in the short run, Prothena Corporation plc’s stock first resistance to watch stands at $6.40. Second resistance stands at $6.58. The third major resistance level sits at $6.70. If the price goes on to break the first support level at $6.10, it is likely to go to the next support level at $5.98. Assuming the price breaks the second support level, the third support level stands at $5.80.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
With a market capitalization of 334.81 million, the company has a total of 53,827K Shares Outstanding. Currently, annual sales are 135,160 K while annual income is -122,310 K. The company’s previous quarter sales were 2,830 K while its latest quarter income was -60,200 K.
